|
2024-02-15 |
2024-02-15 |
B
Purchase
|
ARMEN GARO H
See Remarks
Executive Director
|
500,000
+396.9%
0.65
USD 324,050
|
500,000
+396.9%
|
0.65
|
USD 324,050
|
|
|
2023-11-17 |
2023-11-15 |
B
Purchase
|
WIINBERG ULF
Non-Executive Director
|
25,000
+25.2%
0.76
USD 19,000
|
25,000
+25.2%
|
0.76
|
USD 19,000
|
|
|
2022-01-06 |
2022-01-06 |
S
Sale
|
O'Day Steven J
Chief Medical Officer
Officer
|
38,679
-38.7%
3.06
USD 118,346
|
38,679
-38.7%
|
3.06
|
USD 118,346
|
|
|
2021-09-14 |
2021-09-13 |
S
Sale
|
ARMEN GARO H
Chairman and CEO
Executive Director
|
82,107
-9.6%
6.50
USD 533,696
|
82,107
-9.6%
|
6.50
|
USD 533,696
|
|
|
2021-09-14 |
2021-09-10 |
S
Sale
|
KLASKIN CHRISTINE M
PFO & PAO
Officer
|
11,120
-10.7%
6.50
USD 72,280
|
11,120
-10.7%
|
6.50
|
USD 72,280
|
|
|
2020-06-18 |
2020-06-17 |
S
Sale
|
INCYTE CORP
Large shareholder
|
141,920
-0.8%
3.66
USD 518,831
|
141,920
-0.8%
|
3.66
|
USD 518,831
|
|
|
2020-06-18 |
2020-06-16 |
S
Sale
|
INCYTE CORP
Large shareholder
|
72,080
-0.4%
3.66
USD 264,007
|
72,080
-0.4%
|
3.66
|
USD 264,007
|
|
|
2020-06-15 |
2020-06-15 |
S
Sale
|
INCYTE CORP
Large shareholder
|
384,025
-2.2%
3.57
USD 1,372,160
|
384,025
-2.2%
|
3.57
|
USD 1,372,160
|
|
|
2020-06-15 |
2020-06-12 |
S
Sale
|
INCYTE CORP
Large shareholder
|
9,100
-0.1%
3.58
USD 32,556
|
9,100
-0.1%
|
3.58
|
USD 32,556
|
|
|
2020-06-15 |
2020-06-11 |
S
Sale
|
INCYTE CORP
Large shareholder
|
183,875
-1.0%
3.77
USD 692,786
|
183,875
-1.0%
|
3.77
|
USD 692,786
|
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
Baysal Ozer
Chief Commercial Officer
|
3,712
-5.9%
3.46
USD 12,846
|
3,712
-5.9%
|
3.46
|
USD 12,846
|
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
Valentine Karen
Chief Legal Officer
|
8,358
-7.6%
3.46
USD 28,921
|
8,358
-7.6%
|
3.46
|
USD 28,921
|
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
Duncan Alex
Chief Technology Officer
|
6,546
-23.7%
3.46
USD 22,651
|
6,546
-23.7%
|
3.46
|
USD 22,651
|
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
Buell Jennifer
Chief Communications Officer
|
3,511
-9.0%
3.46
USD 12,152
|
3,511
-9.0%
|
3.46
|
USD 12,152
|
|
|
2017-12-14 |
2017-12-12 |
S
Sale
|
KLASKIN CHRISTINE M
VP, Finance
|
5,610
-8.0%
3.46
USD 19,418
|
5,610
-8.0%
|
3.46
|
USD 19,418
|
|
|
2017-04-12 |
2017-04-12 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Executive Director
|
29,456
+2.1%
3.29
USD 97,055
|
29,456
+2.1%
|
3.29
|
USD 97,055
|
|
|
2017-04-12 |
2017-04-10 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Executive Director
|
70,544
+5.4%
3.37
USD 237,465
|
70,544
+5.4%
|
3.37
|
USD 237,465
|
|
|
2017-02-14 |
2017-02-14 |
B
Purchase
|
INCYTE CORP
Large shareholder
|
10,000,000
+128.8%
6.00
USD 60,000,000
|
10,000,000
+128.8%
|
6.00
|
USD 60,000,000
|
|
|
2016-09-08 |
2016-09-06 |
B
Purchase
|
WIINBERG ULF
Non-Executive Director
|
30,000
+inf%
6.29
USD 188,700
|
30,000
+inf%
|
6.29
|
USD 188,700
|
|
|
2016-05-10 |
2016-05-09 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
50,000
+3.7%
3.28
USD 163,935
|
50,000
+3.7%
|
3.28
|
USD 163,935
|
|
|
2016-05-10 |
2016-05-05 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
50,000
+3.9%
3.08
USD 153,960
|
50,000
+3.9%
|
3.08
|
USD 153,960
|
|
|
2016-05-09 |
2016-05-05 |
B
Purchase
|
Baysal Ozer
Chief Business Officer
Officer
|
2,250
+7.2%
3.10
USD 6,975
|
2,250
+7.2%
|
3.10
|
USD 6,975
|
|
|
2016-03-08 |
2016-03-07 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
200,000
+19.0%
4.03
USD 805,600
|
200,000
+19.0%
|
4.03
|
USD 805,600
|
|
|
2015-12-30 |
2015-12-29 |
S
Sale
|
ARMEN GARO H
Chairman & CEO
Officer
|
85,224
-6.6%
4.57
USD 389,602
|
85,224
-6.6%
|
4.57
|
USD 389,602
|
|
|
2015-12-30 |
2015-12-28 |
S
Sale
|
ARMEN GARO H
Chairman & CEO
Officer
|
89,917
-6.5%
4.59
USD 413,142
|
89,917
-6.5%
|
4.59
|
USD 413,142
|
|
|
2015-12-30 |
2015-12-28 |
S
Sale
|
ARMEN GARO H
Chairman & CEO
Officer
|
44,435
-3.1%
4.62
USD 205,134
|
44,435
-3.1%
|
4.62
|
USD 205,134
|
|
|
2015-09-29 |
2015-09-25 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
100,000
+7.6%
5.03
USD 503,000
|
100,000
+7.6%
|
5.03
|
USD 503,000
|
|
|
2015-09-29 |
2015-09-25 |
B
Purchase
|
Ballantyne Charles Evan
Chief Financial Officer
Officer
|
10,000
+inf%
5.05
USD 50,500
|
10,000
+inf%
|
5.05
|
USD 50,500
|
|
|
2015-04-30 |
2015-04-29 |
S
Sale
|
Malik Shahzad
Non-Executive Director
|
407,377
-100.0%
7.02
USD 2,858,809
|
407,377
-100.0%
|
7.02
|
USD 2,858,809
|
|
|
2015-04-30 |
2015-04-28 |
S
Sale
|
Malik Shahzad
Non-Executive Director
|
700,000
-63.2%
7.16
USD 5,012,560
|
700,000
-63.2%
|
7.16
|
USD 5,012,560
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
41,830
-0.6%
5.33
USD 222,954
|
41,830
-0.6%
|
5.33
|
USD 222,954
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
83,100
-1.2%
5.31
USD 441,261
|
83,100
-1.2%
|
5.31
|
USD 441,261
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
100,000
-1.4%
5.35
USD 535,000
|
100,000
-1.4%
|
5.35
|
USD 535,000
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
89,800
-1.2%
5.49
USD 493,002
|
89,800
-1.2%
|
5.49
|
USD 493,002
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
50,000
-0.7%
5.44
USD 272,000
|
50,000
-0.7%
|
5.44
|
USD 272,000
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
100,000
-1.4%
5.20
USD 520,000
|
100,000
-1.4%
|
5.20
|
USD 520,000
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
43,080
-0.6%
5.57
USD 239,956
|
43,080
-0.6%
|
5.57
|
USD 239,956
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
856,920
-10.3%
5.18
USD 4,438,846
|
856,920
-10.3%
|
5.18
|
USD 4,438,846
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
215,000
-2.5%
5.19
USD 1,115,850
|
215,000
-2.5%
|
5.19
|
USD 1,115,850
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
400,000
-4.5%
5.62
USD 2,248,000
|
400,000
-4.5%
|
5.62
|
USD 2,248,000
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
53,606
-0.6%
5.21
USD 279,287
|
53,606
-0.6%
|
5.21
|
USD 279,287
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
146,394
-1.6%
5.27
USD 771,496
|
146,394
-1.6%
|
5.27
|
USD 771,496
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
143,900
-1.6%
5.30
USD 762,670
|
143,900
-1.6%
|
5.30
|
USD 762,670
|
|
|
2015-01-13 |
2015-01-09 |
S
Sale
|
QVT Associates GP LLC
Large shareholder
|
20,000
-0.2%
5.55
USD 111,000
|
20,000
-0.2%
|
5.55
|
USD 111,000
|
|
|
2011-12-29 |
2011-12-29 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
8,939
-36.6%
2.01
USD 17,967
|
8,939
-36.6%
|
2.01
|
USD 17,967
|
|
|
2011-12-29 |
2011-12-29 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
7,605
-86.5%
1.98
USD 15,058
|
7,605
-86.5%
|
1.98
|
USD 15,058
|
|
|
2011-12-29 |
2011-12-28 |
S
Sale
|
Sharp Shalini
CFO
Officer
|
1,711
-3.9%
2.09
USD 3,576
|
1,711
-3.9%
|
2.09
|
USD 3,576
|
|
|
2011-12-29 |
2011-12-28 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
1,893
-7.2%
2.09
USD 3,956
|
1,893
-7.2%
|
2.09
|
USD 3,956
|
|
|
2011-12-29 |
2011-12-28 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
1,301
-12.9%
2.09
USD 2,719
|
1,301
-12.9%
|
2.09
|
USD 2,719
|
|
|
2011-12-29 |
2011-12-27 |
S
Sale
|
Sharp Shalini
CFO
Officer
|
2,853
-6.2%
2.14
USD 6,105
|
2,853
-6.2%
|
2.14
|
USD 6,105
|
|
|
2011-12-29 |
2011-12-27 |
S
Sale
|
KLASKIN CHRISTINE M
VP, Finance
Officer
|
1,824
-12.6%
2.14
USD 3,903
|
1,824
-12.6%
|
2.14
|
USD 3,903
|
|
|
2011-12-29 |
2011-12-27 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
3,156
-10.7%
2.14
USD 6,754
|
3,156
-10.7%
|
2.14
|
USD 6,754
|
|
|
2011-12-29 |
2011-12-27 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
2,169
-17.7%
2.14
USD 4,642
|
2,169
-17.7%
|
2.14
|
USD 4,642
|
|
|
2011-12-23 |
2011-12-23 |
S
Sale
|
KLASKIN CHRISTINE M
VP Finance
Officer
|
511
-3.4%
2.20
USD 1,123
|
511
-3.4%
|
2.20
|
USD 1,123
|
|
|
2011-12-23 |
2011-12-23 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
886
-2.9%
2.20
USD 1,947
|
886
-2.9%
|
2.20
|
USD 1,947
|
|
|
2011-12-23 |
2011-12-23 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
608
-4.7%
2.20
USD 1,336
|
608
-4.7%
|
2.20
|
USD 1,336
|
|
|
2011-12-23 |
2011-12-23 |
S
Sale
|
Sharp Shalini
CFO
Officer
|
795
-1.7%
2.20
USD 1,747
|
795
-1.7%
|
2.20
|
USD 1,747
|
|
|
2011-12-23 |
2011-12-22 |
S
Sale
|
KLASKIN CHRISTINE M
VP Finance
Officer
|
993
-6.2%
2.19
USD 2,175
|
993
-6.2%
|
2.19
|
USD 2,175
|
|
|
2011-12-23 |
2011-12-22 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
1,716
-5.4%
2.19
USD 3,759
|
1,716
-5.4%
|
2.19
|
USD 3,759
|
|
|
2011-12-23 |
2011-12-22 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
1,177
-8.4%
2.19
USD 2,578
|
1,177
-8.4%
|
2.19
|
USD 2,578
|
|
|
2011-12-23 |
2011-12-22 |
S
Sale
|
Sharp Shalini
CFO
Officer
|
1,548
-3.2%
2.19
USD 3,391
|
1,548
-3.2%
|
2.19
|
USD 3,391
|
|
|
2011-12-23 |
2011-12-21 |
S
Sale
|
KLASKIN CHRISTINE M
VP Finance
Officer
|
1,975
-11.0%
2.24
USD 4,420
|
1,975
-11.0%
|
2.24
|
USD 4,420
|
|
|
2011-12-23 |
2011-12-21 |
S
Sale
|
Wentworth Kerry
VP, Clinical, Reg, & Quality
Officer
|
3,414
-9.6%
2.24
USD 7,641
|
3,414
-9.6%
|
2.24
|
USD 7,641
|
|
|
2011-12-23 |
2011-12-21 |
S
Sale
|
Valentine Karen
VP, General Counsel
Officer
|
2,348
-14.3%
2.24
USD 5,255
|
2,348
-14.3%
|
2.24
|
USD 5,255
|
|
|
2011-12-23 |
2011-12-21 |
S
Sale
|
Sharp Shalini
CFO
Officer
|
3,087
-6.0%
2.24
USD 6,909
|
3,087
-6.0%
|
2.24
|
USD 6,909
|
|
|
2011-10-03 |
2011-09-30 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
16,666
+1.9%
2.99
USD 49,768
|
16,666
+1.9%
|
2.99
|
USD 49,768
|
|
|
2011-08-17 |
2011-08-16 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
2,150,976
+67.7%
0.51
USD 1,096,998
|
2,150,976
+67.7%
|
0.51
|
USD 1,096,998
|
|
|
2010-05-19 |
2010-05-18 |
B
Purchase
|
Wright Timothy
Non-Executive Director
|
10,000
+inf%
1.34
USD 13,400
|
10,000
+inf%
|
1.34
|
USD 13,400
|
|
|
2010-03-18 |
2010-03-16 |
S
Sale
|
Valentine Karen
VP and General Counsel
Officer
|
29,039
-36.1%
0.76
USD 22,006
|
29,039
-36.1%
|
0.76
|
USD 22,006
|
|
|
2009-06-29 |
2009-06-25 |
B
Purchase
|
ARMEN GARO H
Chairman & CEO
Officer
|
25,000
+2.2%
1.97
USD 49,250
|
25,000
+2.2%
|
1.97
|
USD 49,250
|
|
|
2009-02-25 |
2009-02-25 |
B
Purchase
|
HATSOPOULOS JOHN
Non-Executive Director
|
10,000
+22.2%
0.37
USD 3,700
|
10,000
+22.2%
|
0.37
|
USD 3,700
|
|
|
2008-09-05 |
2008-09-04 |
B
Purchase
|
HATSOPOULOS JOHN
Non-Executive Director
|
3,000
+7.1%
1.72
USD 5,160
|
3,000
+7.1%
|
1.72
|
USD 5,160
|
|
|
2008-09-05 |
2008-09-03 |
B
Purchase
|
HATSOPOULOS JOHN
Non-Executive Director
|
7,000
+20.0%
1.71
USD 11,970
|
7,000
+20.0%
|
1.71
|
USD 11,970
|
|
|
2008-05-20 |
2008-05-16 |
B
Purchase
|
MARGARET EISEN
Non-Executive Director
|
15,000
+300.0%
2.36
USD 35,348
|
15,000
+300.0%
|
2.36
|
USD 35,348
|
|
|
2008-01-11 |
2008-01-09 |
B
Purchase
|
ARMEN GARO H
Chairman and CEO
Officer
|
1,166,667
+10.2%
3.00
USD 3,500,001
|
1,166,667
+10.2%
|
3.00
|
USD 3,500,001
|
|
